Company page

Valbiotis Sa

Valbiotis SA is a public company listed on the French market under the ticker ALVAL, with a market capitalization of approximately €36.16 million. The company focuses on the development of innovative solutions for the prevention and management of metabolic diseases. Valbiotis aims to address significant health challenges through its research and product offerings.